ResMed Files Section 337 Patent Complaint on Apnea Treatment Devices
ResMed filed a Section 337 complaint with the International Trade Commission March 28, alleging imports of sleep-disordered breathing treatment systems and components from Apex Medical and Drive Medical Design & Manufacturing infringe its patents. The products are used in the treatment of obstructive sleep apnea by delivering pressurized air to the user to keep that user’s breathing passages open during sleep, the petition for investigation said. According to Resmed, Apex makes infringing breathing treatment systems abroad, and imports them into the U.S. through its affiliate Apex Medical USA. Medical Depot, which does business as Drive Medical Design & Manufacturing, also imports infringing breathing treatment systems it buys from Apex Medical, the complaint alleged. ResMed is requesting the ITC issue limited exclusion and cease and desist orders against the proposed respondents.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
Email ITTNews@warren-news.com